PROFOUND MEDICAL CORP. Basic Shares Outstanding (Weighted Average)
PROFOUND MEDICAL CORP. (PROF) reported Basic Shares Outstanding (Weighted Average) of 36.35 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- PROFOUND MEDICAL CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 36.35M shares, a 20.95% increase year-over-year.
- PROFOUND MEDICAL CORP. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 36.30M shares, a 20.82% increase year-over-year.
- PROFOUND MEDICAL CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 30.57M shares, a 18.60% increase year-over-year.
- PROFOUND MEDICAL CORP. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 30.10M shares, a 22.70% increase year-over-year.
- PROFOUND MEDICAL CORP. weighted average number of shares outstanding, basic for fiscal 2025 was 30.23M shares, a 22.08% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. weighted average number of shares outstanding, basic for fiscal 2024 was 24.77M shares, a 16.91% increase from fiscal 2023.
- PROFOUND MEDICAL CORP. weighted average number of shares outstanding, basic for fiscal 2023 was 21.18M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 36.35M shares 10-Q · filed 2026-08-06 | 36.32M shares 10-Q · filed 2026-08-06 | 34.41M shares derived: average of 3 quarters · filed 2026-08-06 | 33.33M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 36.30M shares 10-Q · filed 2026-05-07 | 33.44M shares derived: average of 2 quarters · filed 2026-05-07 | 32.33M shares derived: average of 3 quarters · filed 2026-05-07 | 31.76M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 30.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 30.34M shares derived: average of 2 quarters · filed 2026-03-05 | 30.24M shares derived: average of 3 quarters · filed 2026-08-06 | 30.23M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 30.10M shares 10-Q · filed 2025-11-13 | 30.08M shares derived: average of 2 quarters · filed 2026-08-06 | 30.12M shares 10-Q · filed 2025-11-13 | 28.99M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 30.05M shares 10-Q · filed 2026-08-06 | 30.06M shares 10-Q · filed 2026-08-06 | 28.62M shares derived: average of 3 quarters · filed 2026-08-06 | 27.60M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 30.04M shares 10-Q · filed 2026-05-07 | 27.91M shares derived: average of 2 quarters · filed 2026-05-07 | 26.78M shares derived: average of 3 quarters · filed 2026-05-07 | 26.20M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 25.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 25.16M shares derived: average of 2 quarters · filed 2026-03-05 | 24.92M shares derived: average of 3 quarters · filed 2026-03-05 | 24.77M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 24.53M shares 10-Q · filed 2025-11-13 | 24.49M shares derived: average of 2 quarters · filed 2025-11-13 | 24.43M shares 10-Q · filed 2025-11-13 | |
| 2024-06-30 | 24.44M shares 10-Q · filed 2025-08-14 | 24.37M shares 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | 24.30M shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 21.18M shares 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |